Journals / Gülhane Tıp Dergisi / 2021 / Cilt: 63 - Sayı: 3

Lactate kinetics in intensive care unit admissions due to diabetic ketoacidosis

Pages
212–217
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, non-survivors(n=6) had significantly higher lactate levels at hospital admission [3.0 (1.3-15.0) vs. 5.1 (3.9-13.5) mmol/L, p=0.017], and ICU admission [2.3 (0.6-9.4) vs. 5.0 (2.4-16.0) mmol/L, p=0.010]than survivors.Conclusions: Although the ICU LOS and mortality did not differ between initial high and lowlactategroups in the present study, the lactate kinetics, especially in the early treatment period,can guide referral to the ICU level of care and determine the DKA patients at higher risk of death.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: We conducted this study to investigate the clinical significance of lactate kinetics inpatients admitted to the intensive care unit (ICU) for diabetic ketoacidosis (DKA).Methods: This retrospective study was conducted between November 1, 2016, and December31, 2020.
📊
Key Findings & Data:Serial lactate measurements (at the hospital admission, ICU admission, and in 24hours periods until 48 hours of ICU stay) of the patients admitted to our ICU with a diagnosisof DKA were recorded.Results: Forty patients were included in the study (mean age: 50.6±19.4 years, female 60%).Eighty-five percent (n=34) of patients had increased (>2 mmol/L) blood lactate levels onadmission.
💡
Conclusion & Impact:Additionally, non-survivors(n=6) had significantly higher lactate levels at hospital admission [3.0 (1.3-15.0) vs. 5.1 (3.9-13.5) mmol/L, p=0.017], and ICU admission [2.3 (0.6-9.4) vs. 5.0 (2.4-16.0) mmol/L, p=0.010]than survivors.Conclusions: Although the ICU LOS and mortality did not differ between initial high and lowlactategroups in the present study, the lactate kinetics, especially in the early treatment period,can guide referral to the ICU level of care and determine the DKA patients at higher risk of death.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Aims: We conducted this study to investigate the clinical significance of lactate kinetics inpatients admitted to the intensive care unit (ICU) for diabetic ketoacidosis (DKA).Methods: This retrospective study was conducted between November 1, 2016, and December31, 2020. Serial lactate measurements (at the hospital admission, ICU admission, and in 24hours periods until 48 hours of ICU stay) of the patients admitted to our ICU with a diagnosisof DKA were recorded.Results: Forty patients were included in the study (mean age: 50.6±19.4 years, female 60%).Eighty-five percent (n=34) of patients had increased (>2 mmol/L) blood lactate levels onadmission. There was no significant difference between the low (lactate <4 mmol/L) and highlactate(lactate ≥4 mmol/L) groups in mortality (p=0.195), ICU stay (p=0.966) and hospitallength of stay (LOS) (p=0.274). However, the group with less than 40% decrease in lactate levelfrom hospital admission to ICU had significantly higher Acute Physiology and Chronic HealthAssessment II score [24 (12-46) vs. 18 (2-27), p=0.007], longer ICU stay [5 (1-40) vs. 3 (2-8) days,p=0.032], and higher mortality rate [6 (26.1) vs. 0 (0.0), p=0.030]. Additionally, non-survivors(n=6) had significantly higher lactate levels at hospital admission [3.0 (1.3-15.0) vs. 5.1 (3.9-13.5) mmol/L, p=0.017], and ICU admission [2.3 (0.6-9.4) vs. 5.0 (2.4-16.0) mmol/L, p=0.010]than survivors.Conclusions: Although the ICU LOS and mortality did not differ between initial high and lowlactategroups in the present study, the lactate kinetics, especially in the early treatment period,can guide referral to the ICU level of care and determine the DKA patients at higher risk of death.

🔖

Cite This Article

TAŞKIN, G., YILMAZ, M., YILMAZ, S., ŞİRİN, H., SAPMAZ, H., TAŞLIGİL, S., GÜNEŞ, İ. S., YAMANEL, L. (2021). Lactate kinetics in intensive care unit admissions due to diabetic ketoacidosis. Gülhane Tıp Dergisi, Cilt: 63 - Sayı: 3, 212–217. https://ajindex.com/articles/347976

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033- 1046
  2. Centers for Disease Control and Prevention. Diabetes Public Health Resource. Accessed date: April 15, 2021. Available from:
  3. Benoit SR, Hora I, Pasquel FJ, Gregg EW, Albright AL, Imperatore G. Trends in Emergency Department Visits and Inpatient Admissions for Hyperglycemic Crises in Adults With Diabetes in the U.S., 2006-2015. Diabetes Care. 2020;43:1057-1064
  4. Gibb FW, Teoh WL, Graham J, Lockman KA. Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia. 2016;59:2082-2087
  5. Cox K, Cocchi MN, Salciccioli JD, Carney E, Howell M, Donnino MW. Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J Crit Care. 2012;27:132-137
  6. Morgan TJ, Scott PH, Anstey CM, Bowling FG. Hyperlactatemia in diabetic ketoacidosis is common and can be prolonged: lactate time-series from 25 intensive care admissions. J Clin Monit Comput. 2021;35:757-764
  7. Vincent JL, Quintairos E Silva A, Couto L Jr, Taccone FS. The value of blood lactate kinetics in critically ill patients: a systematic review. Crit Care. 2016;20:257
  8. Walker CA, Griffith DM, Gray AJ, Datta D, Hay AW. Early lactate clearance in septic patients with elevated lactate levels admitted from the emergency department to intensive care: time to aim higher? J Crit Care. 2013;28:832-837
  9. Hernandez G, Luengo C, Bruhn A, et al. When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring. Ann Intensive Care. 2014;4:30
  10. Freire AX, Umpierrez GE, Afessa B, Latif KA, Bridges L, Kitabchi AE. Predictors of intensive care unit and hospital length of stay in diabetic ketoacidosis. J Crit Care. 2002;17:207-211
  11. Gershengorn HB, Iwashyna TJ, Cooke CR, Scales DC, Kahn JM, Wunsch H. Variation in use of intensive care for adults with diabetic ketoacidosis*. Crit Care Med. 2012;40:2009-2015
  12. Azevedo LC, Choi H, Simmonds K, Davidow J, Bagshaw SM. Incidence and long-term outcomes of critically ill adult patients with moderate-to-severe diabetic ketoacidosis: retrospective matched cohort study. J Crit Care. 2014;29:971-977
  13. Marinac JS, Mesa L. Using a severity of illness scoring system to assess intensive care unit admissions for diabetic ketoacidosis. Crit Care Med. 2000;28:2238-2241
  14. Karoli R, Fatima J, Salman T, Sandhu S, Shankar R. Managing diabetic ketoacidosis in non-intensiv